Brief: Shilpa Medicare Says USFDA Approves NDA Imkeldi Filled By Partner Shorla Oncology
27/11/2024 11:05
Nov 27 (Reuters) - Shilpa Medicare Ltd SHME.NS :
* USFDA APPROVAL OF NDA IMKELDI FILLED BY PARTNER SHORLA
ONCOLOGY
Source text: ID:nBSE8whSvr
Further company coverage: SHME.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Shilpa Medicare
See all newsBrief: Shilpa Medicare Q2 Consol Net Profit INR 791.8 Million
Brief: Shilpa Medicare Says USFDA Conducts Surveillance Inspection At Shilpa Medicare Unit
Brief: Shilpa Medicare Receives Final SEC Approval For Oeris Marketing Authorization
India's Shilpa Medicare gains on approval for OERIS
Brief: Shilpa Medicare Initiates Voluntary Recall Of 27,923 Pemetrexed Injection Vials In Us On July 29, 2026